DENVER, March 08, 2017 -- Global CBD cannabis innovator Elixinol has announced the launch of Respira, a versatile, full-spectrum cannabidiol (CBD) tincture line.
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/802dcf21-081a-4a7a-8b3f-0296cd7f69e6
http://www.globenewswire.com/NewsRoom/AttachmentNg/3c75f9df-ec94-4722-a0f9-5645e457d5bd
http://www.globenewswire.com/NewsRoom/AttachmentNg/65cb132e-206e-47e4-8f54-42bbcd1c3b4d
http://www.globenewswire.com/NewsRoom/AttachmentNg/cfa76333-fc69-49d1-9e69-75a688e06670
Elixinol has developed Respira with all natural ingredients, making Respira a multi-purpose CBD product suitable for consumption orally, topically, or by vape.
As CBD gains in popularity as a cannabis product without psychoactive properties, consumers are seeking ways to incorporate CBD into their daily lives including topical, digestive and vape oil.
“Respira is our most versatile tincture to date, the customer has complete control over the delivery mechanisms,” said Chris Husong, Director of Marketing and Sales of Elixinol. “As cannabis and CBD customers become more educated, we will continue to develop convenient, high-quality products designed for how our customers are using CBD today.”
Each 10 mg serving size of Respira delivers high concentrations of either 300 mg or 600 mg of CBD oil. Respira is sold in two refreshing flavors, grape-mint and natural.
“I use Respira to ease anxiety, pain and headaches associated with my chronic traumatic encephalopathy (CTE). I can use this as a vape oil in my vape pen when I’m on the go,” said CBD advocate and New York Giants Super Bowl champion Leonard Marshall. “This is a product formulated for busy people like me, and it allows me to be my best me.”
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products globally in the United States, Japan, Puerto Rico and the UK. More information is available at Elixinol.com.
Media Contact: Chris Husong Elixinol 844-804-3504 ext 420 [email protected]


Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 



